Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Developing Drugs for Treatment Guidance for Industry

Clinical/Medical

Source: FDA Center for Drug Evaluation and Research - What's New - February 4, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news